Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

Abstract: A practical and reliable online vehicle mass estimation scheme is crucial to effectively control an automated and intelligent vehicle. The Recursive Least Squares with Multiple Forgetting ...

a When photon-pair generation is probabilistic, a two-photon interference measurement between A2 and B1 alone cannot distinguish successful events from unsuccessful ones. Therefore, additional ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

The Federal Trade Commission (FTC), in February 2025, launched a request for information seeking public comment about how social media platforms’ “adverse actions” against users and user content may ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Officials estimate that pythons have killed 95% of small mammals as well as thousands of birds in Everglades National Park Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

The Python Software Foundation warned users this week that threat actors are trying to steal their credentials in phishing attacks using a fake Python Package Index (PyPI) website. PyPI is a ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...